518
Views
33
CrossRef citations to date
0
Altmetric
Reviews

Safety of ceftriaxone sodium at extremes of age

, PharmD, , PharmD, , PharmD, , PharmD & , PharmD
Pages 515-523 | Published online: 01 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Aline Fuchs, Julia Bielicki, Shrey Mathur, Mike Sharland & Johannes N. Van Den Anker. (2018) Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children. Paediatrics and International Child Health 38:sup1, pages S3-S15.
Read now
Alicja Bartkowska-Śniatkowska, Katarzyna Jończyk-Potoczna, Marzena Zielińska & Jowita Rosada-Kurasińska. (2015) Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis. Therapeutics and Clinical Risk Management 11, pages 1035-1041.
Read now

Articles from other publishers (31)

Zon-Min Lee, Ling-Sai Chang, Kuang-Che Kuo, Meng-Chiao Lin & Hong-Ren Yu. (2023) Impact of Protein Binding Capacity and Daily Dosage of a Drug on Total Serum Bilirubin Levels in Susceptible Infants. Children 10:6, pages 926.
Crossref
Mustafa AKÇALI, Hüseyin ŞİMŞEK, Ferda ÖZLÜ, Hacer YAPICIOĞLU & Mehmet SATAR. (2022) Yenidoğanlarda seftriakson kullanımının yan etkilerinin değerlendirilmesiEvaluation of side effects of ceftriaxone use in newborns. Cukurova Medical Journal 47:4, pages 1641-1649.
Crossref
Zon-Min Lee, Yao-Hsu Yang, Ling-Sai Chang, Chih-Cheng Chen, Hong-Ren Yu & Kuang-Che Kuo. (2022) Increased Total Serum Bilirubin Level Post-Ibuprofen Use Is Inversely Correlated with Neonates’ Body Weight. Children 9:8, pages 1184.
Crossref
Soichi Arakawa, Masashi Kasai, Shin Kawai, Hiroshi Sakata & Toshihiko Mayumi. (2021) The JAID/JSC guidelines for management of infectious diseases 2017 – Sepsis and catheter-related bloodstream infection. Journal of Infection and Chemotherapy 27:5, pages 657-677.
Crossref
Anthony Martin Mena, Morgane Masse, Laura Négrier, Thu Huong Nguyen, Bruno Ladam, Laurent Storme, Christine Barthélémy, Pascal Odou, Stéphanie Genay & Bertrand Décaudin. (2021) Optimising an Infusion Protocol Containing Cefepime to Limit Particulate Load to Newborns in a Neonatal Intensive Care Unit. Pharmaceutics 13:3, pages 351.
Crossref
Garrett B. Hile, Kaitlin L. Musick, Adam J. Dugan, Abby M. Bailey & Gavin T. Howington. (2021) Occurrence of Hyperbilirubinemia in Neonates Given a Short-term Course of Ceftriaxone versus Cefotaxime for Sepsis. The Journal of Pediatric Pharmacology and Therapeutics 26:1, pages 99-103.
Crossref
Ophélie Maison, Cléa Tardy, Delphine Cabelguenne, Stéphanie Parat, Sophie Ducastelle, Vincent Piriou, Alain Lepape & Laure Lalande. (2018) Drug incompatibilities in intravenous therapy: evaluation and proposition of preventive tools in intensive care and hematology units. European Journal of Clinical Pharmacology 75:2, pages 179-187.
Crossref
. (2018) JAID/JSC 感染症治療ガイドライン2017 ―敗血症およびカテーテル関連血流感染症―. Kansenshogaku Zasshi 92:1, pages 10-45.
Crossref
Pieter A. J. G. De Cock, Karel Allegaert, Matthew W. Linakis & Catherine M. T. Sherwin. 2018. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill 239 263 .
Elizabeth M. Molyneux, Queen Dube, Francis M. Banda, Msandeni Chiume, Isaac Singini, Macpherson Mallewa, Edward C. Schwalbe & Robert S. Heyderman. (2017) The Treatment of Possible Severe Infection in Infants. Pediatric Infectious Disease Journal 36:12, pages e328-e333.
Crossref
Caroline Fonzo-Christe, Lucie Bouchoud & Riccardo Pfister. (2017) Incompatibilités médicamenteuses et nutrition parentérale en néonatologie. Nutrition Clinique et Métabolisme 31:1, pages 24-27.
Crossref
Patrick C. Donnelly, Rebecca M. Sutich, Ryan Easton, Oluwatunmise A. Adejumo, Todd A. Lee & Latania K. Logan. (2016) Ceftriaxone-Associated Biliary and Cardiopulmonary Adverse Events in Neonates: A Systematic Review of the Literature. Pediatric Drugs 19:1, pages 21-34.
Crossref
Maxime Perez, Aurélie Maiguy-Foinard, Christine Barthélémy, Bertrand Décaudin & Pascal Odou. (2016) Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients. Pharmaceutical Technology in Hospital Pharmacy 1:2.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 180 183 .
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 197 215 .
Young R. Lee, Danni McMahan, Catherine McCall & Gregory K. Perry. (2015) Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players. Drugs 75:18, pages 2097-2117.
Crossref
David Isaacs. 2013. Evidence-Based Neonatal Infections. Evidence-Based Neonatal Infections 269 290 .
Conan MacDougall, B. Joseph Guglielmo & Jeanine Wiener-Kronish. 2011. Anesthetic Pharmacology. Anesthetic Pharmacology 963 986 .
Eman F. Badran, Hamdi A. Battah, Kamal F Akl, Raida W. Khalil & Iyad Al Amori. (2013) Detection of novel LAMA3 mutation in Herlitz junctional epidermolysis bullosa in a Jordanian family . Australasian Journal of Dermatology 54:3, pages 218-221.
Crossref
Cuneyt TaymanMaisa Rayyan & Karel Allegaert. (2011) Neonatal Pharmacology: Extensive Interindividual Variability Despite Limited Size. The Journal of Pediatric Pharmacology and Therapeutics 16:3, pages 170-184.
Crossref
John S. Esterly, Emily Steadman & Marc H. Scheetz. (2011) Impact of the FDA warning of potential ceftriaxone and calcium interactions on drug use policy in clinical practice. International Journal of Clinical Pharmacy 33:3, pages 537-542.
Crossref
Hans-Rudolf Schmutz, Pascal Detampel, Theo Bühler, André Büttler, Benjamin Gygax & Jörg Huwyler. (2011) In Vitro Assessment of the Formation of Ceftriaxone–Calcium Precipitates in Human Plasma. Journal of Pharmaceutical Sciences 100:6, pages 2300-2310.
Crossref
Tore Midtvedt. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 491 508 .
Yohannes Hagos & Natascha A. Wolff. (2010) Assessment of the Role of Renal Organic Anion Transporters in Drug-Induced Nephrotoxicity. Toxins 2:8, pages 2055-2082.
Crossref
Isabella Giorgi, Bertrand Guignard, Caroline Fonzo-Christe & Pascal Bonnabry. (2010) Evaluation of tools to prevent drug incompatibilities in paediatric and neonatal intensive care units. Pharmacy World & Science 32:4, pages 520-529.
Crossref
Emily Steadman, Dennis W. Raisch, Charles L. Bennett, John S. Esterly, Tischa Becker, Michael Postelnick, June M. McKoy, Steve Trifilio, Paul R. Yarnold & Marc H. Scheetz. (2010) Evaluation of a Potential Clinical Interaction between Ceftriaxone and Calcium. Antimicrobial Agents and Chemotherapy 54:4, pages 1534-1540.
Crossref
Hartmut Lode. (2010) Safety and Tolerability of Commonly Prescribed Oral Antibiotics for the Treatment of Respiratory Tract Infections. The American Journal of Medicine 123:4, pages S26-S38.
Crossref
David Greenwood. 2010. Antibiotic and Chemotherapy. Antibiotic and Chemotherapy 170 199 .
. 2010. Meyler's Side Effects of Antimicrobial Drugs. Meyler's Side Effects of Antimicrobial Drugs 1 443 .
Susana Chavez-Bueno & Terrence L. Stull. (2009) Antibacterial Agents in Pediatrics. Infectious Disease Clinics of North America 23:4, pages 865-880.
Crossref
Tore Midtvedt. 2009. 413 425 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.